Shuttle Pharmaceuticals Holdings (SHPH) Notes Payables (2021 - 2025)

Shuttle Pharmaceuticals Holdings' Notes Payables history runs 5 years deep, the most recent figure standing at $65326.0 for Q2 2025.

• In Q2 2025, Notes Payables fell 92.09% year-over-year to $65326.0; the TTM figure through Jun 2025 stood at $65326.0 (down 92.09% YoY), while the FY2024 annual figure was $190270.0, down 68.08% from the prior year.
• Notes Payables was $65326.0 for Q2 2025 at Shuttle Pharmaceuticals Holdings, down from $190270.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $826235.0 in Q2 2024 to a low of $65326.0 in Q2 2025.
• Historically, Notes Payables has averaged $464671.9 across 5 years, with a median of $595999.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Notes Payables surged 111.47% in 2024, then slumped 92.09% in 2025.
• A 5-year view of Notes Payables shows it stood at $685473.0 in 2021, then changed by 0.0% to $685473.0 in 2022, then fell by 13.05% to $595999.0 in 2023, then sank by 68.08% to $190270.0 in 2024, then sank by 65.67% to $65326.0 in 2025.
• The last three Notes Payables figures came in at $65326.0 (Q2 2025), $190270.0 (Q4 2024), and $250000.0 (Q3 2024), per Business Quant data.